Mirum Pharmaceuticals, Inc.

Associate Director, Regional Access Specialist

Mirum Pharmaceuticals, Inc.  •  United States (Remote)  •  2 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.

The Regional Access Specialist (RAS) will work with major cross-functional teams at the customer level and provide customized support for the reimbursement and market access experience for Mirum FDA approved products. These products currently include LIVMARLI, CHOLBAM, CTEXLI, and any future FDA approved products or indications. Patient services and access to Mirum products are offered to customers exclusively through the Mirum Access Plus (MAP) program. This individual is responsible for providing internal and external customers access and reimbursement education to support timely patient access to Mirum products. This individual will work closely with the sales, market access, MAP, medical and marketing functions on reimbursement-related issues. This individual will provide patient specific, insurance policy education to help HCP accounts with the prior authorization and appeals processes. Requires strong cross functional leadership and collaboration to solve complex challenges in cases and master use of the internal CRM System.

***This candidate should live in the Midwest.***

JOB FUNCTIONS/RESPONSIBILITIES

  • Partnering with Mirum stakeholders on overall account and territory strategy to maximize internal/external functional customer knowledge on payor policy and MAP processes.
  • Acting as a subject matter expert on the reimbursement/access landscape relevant to Mirum therapies for the treatment of cholestatic liver disease. This includes payer policies, prior authorization requirements, denials, appeals, peer to peer, and other education required to navigate access for indicated patients.
  • Analyzing and sharing insights on the reimbursement/access experience for Mirum therapies.
  • Proactively providing targeted education to HCP office staff on Mirum Access Plus and the access process to supplement knowledge gaps.
  • Providing RAMs and HCP offices with patient specific, payer policy education to support the prior authorizations and appeals process for MAP consented, on label patients
  • Collaborating with MAP supervisor and HCP accounts on individual case management needs related to HCP education on reimbursement issues.
  • Offering operational solutions and/or identify opportunities to enhance HCP’s access experience by trouble shooting HCP account access issues and collecting HCP account feedback
  • Conducting access related business reviews with higher volume HCP accounts to keep them informed of account specific as well as national trends
  • Attending weekly regional team meetings and keeping regional teams informed of access trends with patient enrollment forms and RAS activities with key accounts
  • Supporting the continuing improvement and education of MAP Patient Navigators by providing feedback in call calibration sessions and designing/conducting training to support any knowledge gaps
  • Developing compliant and customer-centric reimbursement educational materials
  • Requires strong cross functional leadership and collaboration to solve complex challenges in cases.
  • Mastery of data utilized in cases to ensure accurate flow of information.
  • Complying with all laws, regulations, and policies that govern the conduct of Mirum activities.
  • Other duties and projects as assigned.

QUALIFICATIONS

Education/Experience:

  • Bachelor’s degree in business, science or related field
  • 8 years of pharmaceutical or biotech experience
  • 4 or more years of experience with specialty products in the orphan or rare disease space required
  • 3 years of experience in the following functions is strongly preferred: field reimbursement, patient access and support, payer account management, market access strategy and operations within the pharmaceutical or biotech industry
  • Strong understanding of payer landscape, payer accounts, and market access experience required
  • Ability to travel up to 50% of time

KNOWLEDGE, SKILLS, AND ABILITIES

  • Strongly embodying Mirum core values: care, be real, get it done, and have fun, seriously
  • Ability to anticipate and resolve problems effectively
  • Clear, accurate, and concise written and oral communication skills
  • High demonstratable proficiency in Excel and PowerPoint
  • Effectively organize and prioritize various activities
  • Demonstrated flexibility in working with people, processes, and systems in a complex environment
  • Ability to multi-task and be responsive to internal and external customers, even while on business travel
  • Influences without authority and successfully collaborates cross-functionally
  • Result and goal oriented, committed to contribute to the overall success of Mirum

#LI-REMOTE

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

Mirum Pharmaceuticals, Inc.

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets.

LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.

Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder.

Industry
Chemicals & Materials
Company Size
201-500 employees
Headquarters
Foster City, CA
Year Founded
2018
Social Media